TB

Thomas Butler

BF Biomea Fusion: 10 patents #1 of 36Top 3%
GS Gilead Sciences: 7 patents #209 of 952Top 25%
3M: 2 patents #5,326 of 11,543Top 50%
📍 Redwood City, CA: #428 of 5,061 inventorsTop 9%
🗺 California: #27,156 of 386,348 inventorsTop 8%
Overall (All Time): #200,893 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
12275739 Inhibitors of menin-MLL interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2025-04-15
12251385 Covalent inhibitors of menin-MLL interaction for diabetes mellitus James T. Palmer 2025-03-18
12116371 Substituted pyridines as irreversible inhibitors of menin-MLL interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2024-10-15
12077544 Irreversible inhibitors of menin-MLL interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2024-09-03
12018032 Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction Priyanka Somanath, Daniel C. Lu, Taisei Kinoshita, Brian Keith Law, James T. Palmer +5 more 2024-06-25
11945785 Pyrazine compounds as inhibitors of FLT3 David Sperandio, Xiaodong Wang, Thorsten A. Kirschberg, James T. Palmer, Solomon Ungashe +6 more 2024-04-02
11845753 Inhibitors of menin-mll interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2023-12-19
11702421 Substituted pyridines as irreversible inhibitors of menin-MLL interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2023-07-18
11174263 Inhibitors of menin-MLL interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2021-11-16
11084825 Substituted pyridines as irreversible inhibitors of menin-MLL interaction Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly +1 more 2021-08-10
10988498 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs Aesop Cho, Benjamin R. Graetz, Choung U. Kim, Samuel E. Metobo, Oliver L. Saunders +3 more 2021-04-27
10023600 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs Aesop Cho, Benjamin R. Graetz, Choung U. Kim, Samuel E. Metobo, Oliver L. Saunders +3 more 2018-07-17
RE46762 1′-substituted carba-nucleoside analogs for antiviral treatment Aesop Cho, Choung U. Kim, Jay P. Parrish, Oliver L. Saunders, Lijun Zhang 2018-03-27
9828722 Blends of fluoroalkyl-containing ester oligomers with polycarbodiimide(s) Chetan P. Jariwala, Cheryl L. S. Elsbernd 2017-11-28
8993116 Blends of fluoroalkyl-containing ester oligomers with polydicarbodiimide(S) Chetan P. Jariwala, Cheryl L. S. Elsbernd 2015-03-31
8853171 1′-substituted carba-nucleoside analogs for antiviral treatment Aesop Cho, Choung U. Kim, Jay P. Parrish, Oliver L. Saunders, Lijun Zhang 2014-10-07
8318682 1′substituted carba-nucleoside analogs for antiviral treatment Aesop Cho, Choung U. Kim, Jay P. Parrish, Oliver L. Saunders, Lijun Zhang 2012-11-27
8012942 Carba-nucleoside analogs for antiviral treatment Aesop Cho, Choung U. Kim, Jie Xu 2011-09-06
8008264 1′-substituted carba-nucleoside analogs for antiviral treatment Aesop Cho, Choung U. Kim, Jay P. Parrish, Oliver L. Saunders, Lijun Zhang 2011-08-30
5018706 Apparatus for inhibiting stress corrosion cracking David Sancic 1991-05-28
4948435 Method for inhibiting stress corrosion cracking David Sancic 1990-08-14